Increasing COVID-19 Vaccine Uptake in Developing Countries (Bihar)
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
The goal of the study is to identify strategies that best promote and support COVID vaccine uptake in developing countries, we propose to test a range of scalable social and behavioural interventions. This could help policy makers design and employ interventions that are effective. This is especially valuable in resource constrained contexts where funds and institutional resources can be diverted towards interventions that have proven to work.
In Bihar the intervention will be village-level social mobilization involving community promotion, including in-person vaccine reinforcement, and household-level social mobilization. Some treatment villages will receive household- level interventions with varying intensity (different proportion of households will be visited). There will also an accompanying mask distribution campaign during household visits where the importance of mask-wearing as a complement to vaccine use will be explained.
This ClinicalTrials entry contains results only for the study in Bihar.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Bihar
-
Patna, Bihar, Indien, 800001
- Project Concern International
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Lives in study village
Exclusion Criteria:
- Does not live in study village
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Inget ingripande: Control
No vaccine or mask promotion, but access to vaccines increased to match access in intervention villages
|
|
|
Experimentell: Village-level vaccine clinics with monetary, non-monetary, or no incentive
Village-level vaccine clinics with monetary, non-monetary, or no incentive.
Villages are cross-randomized to grocery coupon, food ration, no incentive, or grocery coupon to both community member and community health worker after the community member has received a vaccination.
|
Individuals will be provided with a guaranteed cash payment, entry into a cash lottery, or guaranteed gift of food if they are vaccinated
Vaccines are conducted at the household-level rather than the village-level
Village-level social mobilization campaign to be vaccinated
|
|
Experimentell: Household-level vaccination with monetary or no incentive
Household-level vaccination with monetary incentive or no incentive.
Villages are cross-randomized to grocery coupon or no incentive upon receiving vaccination
|
Individuals will be provided with a guaranteed cash payment, entry into a cash lottery, or guaranteed gift of food if they are vaccinated
Vaccines are conducted at the household-level rather than the village-level
Village-level social mobilization campaign to be vaccinated
|
|
Experimentell: Village-level vaccination without incentive, plus mask promotion
Individuals are encourage to attend village-level vaccine clinics but not given any incentive.
Mask distribution and reinforcement activities are conducted in villages at a similar time as vaccine promotion.
|
Vaccines are conducted at the household-level rather than the village-level
Village-level social mobilization campaign to be vaccinated
Individuals are given cloth masks
Individuals who are not wearing masks over their mouth and nose are stopped in public places and encouraged to wear a mask
|
|
Experimentell: Village-level vaccination without incentive
Individuals are encourage to attend village-level vaccine clinics but not given any incentive.
|
Vaccines are conducted at the household-level rather than the village-level
Village-level social mobilization campaign to be vaccinated
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Percent of individuals who receive the first, second, or third dose of covid vaccine
Tidsram: up to 4 weeks (endline may vary depending on estimated uptake rates)
|
Prevalence of vaccination with difference doses
|
up to 4 weeks (endline may vary depending on estimated uptake rates)
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2000031541
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .